Market Growth Factors-
Growth in
Neuroscience Antibodies and Assays Market is driven by the rising
incidence of neurological diseases, increasing investments in
neuroscience research, and growth in the pharmaceutical and
biotechnology industries.
According to research report the Neuroscience Antibodies Market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=129888612
Top Segments –
The
Neuroscience Antibodies Market are segmented based on product,
technology, application, end user, and region. Based on product, the
Neuroscience Antibodies Market are segmented into consumables and
instruments. The consumables segment is expected to account for the
largest market share in 2018 and is expected to register the highest
CAGR during the forecast period. The consistent usage of consumables and
their frequent purchases, and rising government initiatives in the
genomics and proteomics research sector is the major factor supporting
the growth of the consumables segment during the forecast period. Based
on type, the consumables market is segmented into reagents, antibodies,
and assays kits. The reagents segment is expected to account for the
largest share in 2018. The large share of this segment is attributed to
the high consumption of reagents in various routine assays and
techniques.
The immunoassays/immunochemistry segment is expected to dominate the market in 2018
Based
on technology, the Neuroscience Antibodies and Assays Market are
segmented into immunoassays/immunochemistry, molecular diagnostics,
clinical chemistry, and other technologies. In 2018,
immunoassays/immunochemistry segment is expected to account for the
largest share of the neuroscience antibodies and assays market. The
large share of this segment is attributed to the development of novel
antibodies and assays for immunoassay techniques, technological
developments in immunoassays, and rising government initiatives in the
genomics and proteomics research sector.
Based on application, the in vitro diagnostics segment is expected to register the highest CAGR during the forecast period
Based
on application, the Neuroscience Antibodies and Assays Market are
segmented into research, drug discovery and development, and in vitro
diagnostics. The in vitro diagnostics applications segment is expected
to register the highest CAGR during the forecast period. The high growth
of this segment is attributed to the increasing incidence and
prevalence of neurological diseases across the globe, especially in
developing countries.
Get Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=129888612
